These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4729321

  • 1. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ, Hasler E, Sonntag RW, Cavalli F, Martin J, Tschopp L, Brunner KW.
    Schweiz Med Wochenschr; 1977 Jul 02; 107(26):912-5. PubMed ID: 877537
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy in bronchogenic carcinoma.
    Ojala A, Nikkanen VN, Palojoki A, Paloheimo S.
    Ann Clin Res; 1977 Feb 02; 9(1):12-4. PubMed ID: 329741
    [Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD, Desser RK, DeMeester TR, Colman M, Evans R, Billings A, Griem M, Rubenstein L, Shapiro C, Golomb HM.
    Cancer Treat Rep; 1976 Sep 02; 60(9):1225-30. PubMed ID: 189920
    [Abstract] [Full Text] [Related]

  • 7. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
    Alberto P, Brunner KW, Martz G, Obrecht J, Sonntag RW.
    Cancer; 1976 Dec 02; 38(6):2208-16. PubMed ID: 187313
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E.
    Prax Klin Pneumol; 1980 Dec 02; 34(12):719-23. PubMed ID: 7465532
    [No Abstract] [Full Text] [Related]

  • 9. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].
    Castberg T, Kruse-Blinkenberg HO.
    Ugeskr Laeger; 1976 Jun 07; 138(24):1449-55. PubMed ID: 1273973
    [No Abstract] [Full Text] [Related]

  • 10. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD, Desser RK, DeMeester T, Golomb HM.
    JAMA; 1978 Dec 15; 240(25):2743-6. PubMed ID: 713008
    [Abstract] [Full Text] [Related]

  • 11. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U.
    Rontgenblatter; 1977 Apr 15; 30(4):196-201. PubMed ID: 67629
    [Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung.
    Eagan RT, Maurer LH, Forcier RJ, Tulloh M.
    Cancer; 1973 Aug 15; 32(2):371-9. PubMed ID: 4722918
    [No Abstract] [Full Text] [Related]

  • 13. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
    Lad T, Sarma PR, Diekamp U, Tichler T, Chawla M, Krauss S, Zawila P, Nelson R.
    Cancer Clin Trials; 1979 Aug 15; 2(4):321-6. PubMed ID: 394868
    [Abstract] [Full Text] [Related]

  • 14. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
    Bitran JD, Desser RK, DeMeester T, Shapiro CM, Billings A, Rubenstein L, Evans R, Colman M, Rao CY, Griem M, Golomb HM.
    Cancer Treat Rep; 1978 Mar 15; 62(3):327-32. PubMed ID: 348305
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
    Bonadonna G, Tancini G, Bajetta E.
    Cancer Chemother Rep 3; 1973 Mar 15; 4(2):231-7. PubMed ID: 4125741
    [No Abstract] [Full Text] [Related]

  • 16. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB.
    Cancer Treat Rev; 1977 Sep 15; 4(3):153-65. PubMed ID: 73419
    [No Abstract] [Full Text] [Related]

  • 17. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ, Bonomi PD, Rossof AH, Wolter J.
    Cancer Treat Rep; 1978 Oct 15; 62(10):1595-7. PubMed ID: 709563
    [No Abstract] [Full Text] [Related]

  • 18. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H, Fritsch H, Drings P, Moskwa G, von Kaick G.
    Med Klin; 1974 Apr 26; 69(17):750-6. PubMed ID: 4837493
    [No Abstract] [Full Text] [Related]

  • 19. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
    Brunner KW, Marthaler T, Müller W.
    Cancer Chemother Rep 3; 1973 Mar 26; 4(2):125-32. PubMed ID: 4199643
    [No Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A, Nikkanen VN, Paloheimo S, Palojoki A, Thölix E.
    Strahlentherapie; 1983 Dec 26; 159(12):775-7. PubMed ID: 6364459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.